News

Kyndryl Holdings (NYSE: KD) looks like an expensive stock. The IT infrastructure specialist trades at 61 times GAAP earnings, and its free cash flows have been negative across the past four

Quantum computing expert IonQ (NYSE: IONQ) is riding a Wall Street roller coaster these days. After trading largely sideways in their first three and a half years on the stock market, IonQ shares

There's no denying it. Apple (NASDAQ: AAPL) was not only late to the artificial intelligence party, but it has struggled to catch up.

While the world was admittedly interested in Apple

In 2022, the yield curve, which maps yields on U.S. Treasury bonds of different maturities, became inverted, meaning short-term Treasuries had higher yields than longer-dated ones. This inversion

This might surprise some, but Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) has significantly lagged the market in the past year. The drugmaker's shares are down by 40% over the

Despite a strong rebound this month, ConocoPhillips (NYSE: COP) stock remains cheap, according to several valuation metrics. But you need to be looking ahead, not behind, to see it. That's because

Copper miner Freeport-McMoRan's (NYSE: FCX) stock is down 37% from its all-time high, yet the price of copper is almost at an all-time high. While the company's news hasn't been entirely positive

Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but

Following the presidential election last November, Bitcoin's (CRYPTO: BTC) price soared 54% in just six weeks. After trading in a relatively narrow range through the first couple of months of 2025,

There's no denying that when Warren Buffett speaks, investors tend to listen. That's the attention you receive when you've built a trillion-dollar business -- Berkshire Hathaway (NYSE: BRK.A)(NYSE:

Micron Technology (NASDAQ: MU) recently reported another quarter of strong demand for its memory products. Baird analyst Tristan Gerra updated his guidance as a result, maintaining an outperform

Over the last couple of years, the pharmaceutical sector has captivated investors thanks in large part to novel medications used to treat chronic weight management and diabetes.

While you may be

While Wall Street analysts project a healthy 10% total return for the S&P 500 in 2025, reality has painted a different picture. Nearly three months into the year, the benchmark index has retreated

Need dividend income? You can't do much better than tobacco giant Altria (NYSE: MO). Not only has it paid a dividend like clockwork every quarter for decades now, it has raised its per-share payout

After stellar performances in 2023 and 2024 that resulted in a two-year gain of 84.5%, the Nasdaq Composite fell as low as 17,303.01 on March 13 -- a drop of 14.2% drop from the high of 20,173.89 it

Richard Bernstein is the CEO and chief investment officer at Richard Bernstein Advisors. In this podcast, he joins Motley Fool host Ricky Mulvey for a conversation about:

To catch full episodes of

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda. While there are concerns about its patent losses in the future, its sales are still

Coffee chain Dutch Bros (NYSE: BROS) is on a roll, and I don't mean with ham and cheese. The stock has more than doubled in six months as Dutch Bros keeps crushing earnings and revenue estimates in

Want to buy a good dividend stock and secure a great price in the process? I have a list of three stocks that can help you diversify your portfolio, allow you to earn above-average dividends, and